Immune checkpoint blockade therapy in head and neck cancer: a review

• Egile Nagusiak: Shajedul Islam (Egilea), Md Shahed Rafi Pavel (Egilea), Syed Taufiqul Islam (Egilea), Nazmus Shalehin (Egilea), Shahed Jahan Babu (Egilea)
• Formatua: Liburua
• Argitaratua: Update Dental College, 2018-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Head and neck cancer (HNC) is a common malignant tumor, carrying a poor prognosis, and despite advances in oncology, this rate has not improved significantly for decades. It has recently been evaluated that the immunologic checkpoint inhibitors become a novel promising strategic immunotherapy in the...